Anti Cancer Drugs

                                              Glivec 100mg PRODUCT DETAILS Active component : Imatinib Strength : 100mg Pack : 28 tablets in a container  DESCRIPTION  Glivec 100mg is a antineoplastic agents and used by alone regimen or together with other medicines for the treatment of different types of cancer or bone marrow conditions, the main ingredient which is used as imatinib .  Glivec 100mg  will prevents the development of cancer cells in the body. DOSAGE Adult : PO Chronic myeloid leukaemia • Chronic phase: The patients with Chronic phase the drug administrated 400 mg per day, given up to 600 mg/day or 400 mg bid if needed.  Glivec 100mg   The patients with Blast crisis or accelerated phase administrated 600 mg per day, up to 400 mg bid if required. Acute lymphoblastic leukaemia :Dose of 600 mg per day with induction, consolidation or maintenance therapy ; Monotherapy in relapsed or refractory acute lymphoblastic leukaemia 400 mg per day up to 4

                                      BORTEZOMIB 1MG PRODUCT DETAILS Composition : Bortezomib Strength availability : 1mg vial Form : injection Pack : 1mg containing vial in a carton DESCRIPTION Bortezomib is a drug sold under the brand name of Velcade 1mg which belongs to anti-neoplastic medicine, which is available in the form of lyophilized powder. Velcade 1mg is a prime benign proteasome inhibitor; proteasome is a biological structure that clefts the proteins Pharmacological grouped as: anti-neoplastic agent or proteasome inhibitor The drug is a prescription drug given under the supervision of pharmacist. INDICATION Velcade 1mg  is majorly indicated for the treatment for patients suffering by following disease. Multiple myeloma Mantle cell lymphoma. DOSAGE In adults: Multiple myeloma: Previously untreated multiple myeloma in the therapy: Velcade 1mg  dose 1.3mg/m2 should be given as 3 to 5 seconds via IV bolus or subcutaneous by interacting with tablet me

                                      MYEZOM - 2MG PRODUCT DETAILS Trade name : Myezom Active component : Bortezomib Strength of the component : 2mg vial Manufactured by : DR.Reddy's Pack : 2mg Bortezomib containing vial in a carton Dosage form : lyophilized powder                                                                   Category : Anti-cancer drug; proteasome inhibitor DEFINITION Bortezomib is a drug sold under the brand name of Myezom 2mg which belongs to anti-neoplastic medicine, the main ingredient which is used as bortenat , which is available in the form of lyophilized powder  Myezom 2mg  is a prime benign proteasome inhibitor; proteasome is a biological structure that clefts the proteins Pharmacological grouped as: anti-neoplastic agent or proteasome inhibitor The drug is an prescription drug given under the supervision of pharmacist PHARMACOKINETICS Absorption: The  Myezom 2mg  peak plasma level occurs as 509ng/ml Distribution:

                                       BORTENAT - 2MG PRODUCT DETAILS Trade name : Bortenat Active component : Bortezomib Strength of the component : 2mg vial Manufactured by : Natco pharma Pack : 2mg Bortezomib containing vial in a carton Dosage form : lyophilized powder Category : Anti-cancer drug; proteasome inhibitor DEFINES Bortezomib is a drug sold under the brand name of Bortenat 2mg injection which belongs to anti-neoplastic medicine, the main ingredient which is used as bortenat , which is available in the form of lyophilized powder Bortenat 2mg is a prime benign proteasome inhibitor; proteasome is a biological structure that clefts the proteins Pharmacological grouped as: anti-neoplastic agent or proteasome inhibitor The drug is an prescription drug given under the supervision of pharmacist PHARMACOKINETICS Absorption: The  Bortenat 2mg  peak plasma level occurs as 509ng/ml Distribution: The  Bortenat 2mg  has nearly 83% of human plasma prote